Washington Trust Advisors, Inc. Novo Nordisk A S Transaction History
Washington Trust Advisors, Inc.
- $1.09 Billion
- Q1 2025
A detailed history of Washington Trust Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 778 shares of NVO stock, worth $61,718. This represents 0.0% of its overall portfolio holdings.
Number of Shares
778
Previous 518
50.19%
Holding current value
$61,718
Previous $44,000
22.73%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.49 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.17 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$983 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$977 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$942 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $179B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...